Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis

doi:10.12998/wjcc.v10.i5.1527

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4205)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-6) series.

Item

Count

PDF

233

WORD

HTML

2107

Figures (1-1)

299

Tables (1-6)

307

Sum=3041

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

377

Download

787

Sum=1164

Feb 16, 2022 (publication date) through Nov 17, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Feb 16, 2022; 10(5): 1527-1535
Published online Feb 16, 2022. doi: 10.12998/wjcc.v10.i5.1527

Full Size Figure Download Figure

Figure 1 Flow chart of the selection of the three groups of study participants. T2DM: Type 2 diabetes mellitus.

Citation: Xie FF, Zhang YF, Hu YF, Xie YY, Wang XY, Wang SZ, Xie BQ. Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis. World J Clin Cases 2022; 10(5): 1527-1535
URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1527.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i5.1527